Abstract 1619: ERK-targeted therapy suppresses tumorigenicity in ovarian clear cell carcinoma and is modulated by ERK-binding protein PEA-15

Ovarian clear cell carcinoma (CCC) has shown resistance to the current standard chemotherapy used for epithelial ovarian cancer (EOC). Therefore, developing a novel therapeutic strategy is imperative to improve the prognosis for patients with CCC. Epidermal growth factor receptor (EGFR) is frequentl...

Full description

Bibliographic Details

Published in:	Cancer research (Chicago, Ill.) Vol. 70; no. 8_Supplement; p. 1619
Main Authors:	Oishi, Tetsuro, Bartholomeusz, Chandra, Kazansky, Anna, Akar, Ugur, Krishunamurthy, Savitori, Esteva, Francisco J., Itamochi, Hiroaki, Ueno, Naoto T.
Format:	Journal Article
Language:	English
Published:	15-04-2010
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!